RxDoctor Payments Data

Scott Snyder, MD

Psychiatry · Athens, GANPI 1679619183

Payments from drug & device makers

$251in general payments, 2019–2025

Across 14 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$47
  • Otsuka America Pharmaceutical, Inc.$32
  • Johnson & Johnson$27
  • Ironshore Pharmaceuticals Inc.$24
  • Shire North American Group Inc$22
  • Jazz Pharmaceuticals Inc.$20
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$251 in reported general payments places this provider in the 40th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$35,754
Medicare patients
103
Services billed
315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FanaptIloperidone14$23,394
VraylarCariprazine Hcl12$16,887
Chlorpromazine Hcl22$9,189
Paliperidone ErPaliperidone12$4,929
Bupropion Hcl SrBupropion Hcl224$4,020
VyvanseLisdexamfetamine Dimesylate11$3,958
Quetiapine Fumarate303$3,764
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine121$3,618
Olanzapine159$3,285
Atomoxetine Hcl32$3,042
Trazodone Hcl247$2,860
Lisdexamfetamine Dimesylate15$2,701
Gabapentin242$2,390
Aripiprazole86$2,304
Fluoxetine Hcl291$1,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Vanda Pharmaceuticals Inc.Fanapt$15$23,39414 claims
AbbVieVraylar$47$16,88712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →